Industrial LeadershipPublication date: 14 October 2015
Opening date: 26 November 2015
- Enhancing profitability and growth performance of SMEs by combining and transferring new and existing knowledge into innovative, disruptive and competitive solutions seizing European and global business opportunities.
- Market uptake and distribution of innovations[[In the case of SMEInst-05-2016-2017, the development of innovative solutions should lead to value creation through the increased use of cell-based products/processes, biomarkers and/or diagnostic medical devices in industrial or clinical settings, and should contribute to technical and regulatory progress in these domains.]] tackling the specific challenges in a sustainable way.
- Increase of private investment in innovation, notably leverage of private co-investor and/or follow-up investments.
- The expected impacts should be clearly described in qualitative and quantitative terms (e.g. on turnover, employment, market seize, IP management, sales, return on investment and profit).
The budget available for phase 1 and phase 2 will be divided equally between each cut-off date.
Up to 10 % of the annual budget will be used for phase 1 funding; 87% of the annual budget for phase 2 funding; at least 1% will be used for phase 3 related actions. In addition, 1% of the budget will be used to support coaching and mentoring activities supporting phase 1 and 2. Other than that, up to 1% of the annual budget will be used for evaluation.
The SME instrument consists of three phases, including a coaching and mentoring service for beneficiaries. Participants can apply to phase 1 or directly to phase 2.
In 2016 and 2017, SMEs are invited to submit proposals under the SME instrument at any time within all Societal Challenges and Leadership in Enabling and Industrial Technologies areas under the following call-
More information here.